Detalles de la búsqueda
1.
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
BMC Cancer;
24(1): 16, 2024 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38166764
2.
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.
BMC Cancer;
23(1): 136, 2023 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36765293
3.
Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data.
Support Care Cancer;
31(12): 624, 2023 Oct 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37819422
4.
Real-life experience of patients with sarcomatoid renal cell carcinoma: a multicenter retrospective study.
Neoplasma;
70(1): 158-165, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36620878
5.
The risk of malnutrition and its clinical implications in older patients with cancer.
Aging Clin Exp Res;
35(11): 2675-2683, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37644257
6.
Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study.
Future Oncol;
18(23): 2573-2582, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35734870
7.
Impact of coronaphobia on treatment and follow-up compliance of cancer patients.
Future Oncol;
17(20): 2621-2629, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33880932
8.
Assessment of abuse and related factors in older patients with cancer.
Support Care Cancer;
29(12): 7957-7964, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34213643
9.
Effects of adenosine triphosphate on vandetanib induced skin damage in rats.
Cutan Ocul Toxicol;
39(4): 323-327, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32722951
10.
Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
BMC Cancer;
24(1): 114, 2024 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38262962
11.
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.
BMC Cancer;
23(1): 192, 2023 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36849943
12.
The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing.
J Chemother;
: 1-9, 2024 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38263804
13.
Efficacy and safety of concomitant chemo-endocrine therapy in neoadjuvant treatment of hormone-positive HER2-negative breast cancer: a systemic review and meta-analysis.
Expert Opin Drug Saf;
22(4): 313-322, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37057733
14.
Comparison of HER2-zero and HER2-low in terms of clinicopathological factors and survival in early-stage breast cancer: A systematic review and meta-analysis.
Cancer Treat Rev;
115: 102538, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36898351
15.
Dynamic changes in systemic immune-inflammation index predict pathological tumor response and overall survival in patients with gastric or gastroesophageal junction cancer receiving neoadjuvant chemotherapy.
Asia Pac J Clin Oncol;
19(1): 104-112, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35538045
16.
Adoptive Cell Therapy in Hepatocellular Carcinoma: A Review of Clinical Trials.
Cancers (Basel);
15(6)2023 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980692
17.
The Effect of HER2-Low Status on Pathological Complete Response and Survival in Triple-Negative Breast Cancer: A Systemic Review and Meta-Analysis.
Clin Breast Cancer;
23(6): 567-575, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37336652
18.
Association of Serum Hepatocyte Growth Factor Level with Systemic Inflammatory Biomarkers in Patients with Pancreatobiliary Cancer.
Turk J Gastroenterol;
34(5): 568-575, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36789987
19.
Recommendations of the International Society of Geriatric Oncology on skin cancer management in older patients.
J Geriatr Oncol;
14(4): 101502, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37080793
20.
The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study.
J Chemother;
35(1): 19-28, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35174772